ENGLEWOOD, Colo.--(BUSINESS WIRE)--Inhibiton Therapeutics, Inc. (OTCBB: IHBT) announced today that it has filed a Current Report on Form 8-K (the “8-K Report”) that provides an update on its research activities. The 8-K Report is based on an update from the primary researcher, Dr. Mildred Acevedo-Duncan, Ph.D., as to the progress of the research project the Company has been funding since September 2004 at the James A. Haley Veterans’ Hospital in Tampa, Florida.
